Noveris Health Sciences is trading at CA$0.04, down 10%, with the reason for the decline unclear.

  • The company’s news page lists no October 26 announcement; its latest listed release is dated September 9, 2026.
  • No clear company-specific catalyst or trading-volume details were found.
  • Major U.S. indexes were higher, so the provided market context does not explain the decline as a broad same-direction move.